SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 34 filers reported holding SIGILON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $688,962 | +165.7% | 740,740 | 0.0% | 0.23% | +166.7% |
| Q4 2022 | $259,259 | -30.7% | 740,740 | 0.0% | 0.09% | -28.7% |
| Q3 2022 | $374,000 | -39.2% | 740,740 | 0.0% | 0.12% | -39.6% |
| Q2 2022 | $615,000 | -43.5% | 740,740 | 0.0% | 0.20% | -9.0% |
| Q1 2022 | $1,089,000 | -46.7% | 740,740 | 0.0% | 0.22% | -14.9% |
| Q4 2021 | $2,044,000 | -51.2% | 740,740 | 0.0% | 0.26% | -33.6% |
| Q3 2021 | $4,185,000 | -47.3% | 740,740 | 0.0% | 0.39% | -48.3% |
| Q2 2021 | $7,948,000 | -52.0% | 740,740 | 0.0% | 0.76% | -65.8% |
| Q1 2021 | $16,556,000 | -53.5% | 740,740 | 0.0% | 2.22% | -84.0% |
| Q4 2020 | $35,578,000 | – | 740,740 | – | 13.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 740,740 | $35,578,000 | 13.90% |
| Flagship Pioneering Inc. | 10,370,369 | $498,089,000 | 9.07% |
| Monashee Investment Management LLC | 561,628 | $26,975,000 | 3.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 567,460 | $26,061,000 | 2.31% |
| Avidity Partners Management LP | 688,000 | $33,045,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 225,000 | $10,807,000 | 0.76% |
| Artal Group S.A. | 276,000 | $13,256,000 | 0.28% |
| GILDER GAGNON HOWE & CO LLC | 662,227 | $31,807,000 | 0.16% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,485,185 | $71,333,000 | 0.11% |
| Perceptive Advisors | 125,000 | $6,004,000 | 0.06% |